Imatinib Mesylate(α form)

A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors.

Price Not Available inquiry Imatinib Mesylate(α form) Supplier Page
Catalog Number API220127571-2
Alternative Name(s) Gleevec Glivec Imatinib mesilate
Research Area Anti-Tumor APIs
Molecular Formula C30H35N7O4S
CAS# 220127-57-1
SMILES CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O
Size inquiry
Supplier Page https://www.protheragen-ing.com/imatinib-mesylate-form-item-11802.html

Imatinib Mesylate(β form)

A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors.

Price Not Available inquiry Imatinib Mesylate(β form) Supplier Page
Catalog Number API220127571-1
Alternative Name(s) Gleevec Glivec Imatinib mesilate
Research Area Anti-Tumor APIs
Molecular Formula C30H35N7O4S
CAS# 220127-57-1
SMILES CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O
Size inquiry
Supplier Page https://www.protheragen-ing.com/imatinib-mesylate-form-item-11801.html